November 12, 2025 a 01:01 pm
DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is a solid player in the diagnostic testing industry with a significant presence across the United States and internationally. The stock shows potential for steady growth driven by robust services and a broad network. Investors might find the company's consistent performance metrics appealing, despite current market challenges.
Fundamental Rating
The fundamental analysis of Quest Diagnostics reveals a stable outlook with a solid performance across key financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
The historical performance indicates a consistent rating with stable financial metrics over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | 3 | 4 | 4 | 5 | 1 | 2 | 3 |
| Current | 3 | 4 | 4 | 5 | 1 | 2 | 3 |
Analyst Price Targets
The analyst estimates suggest a balanced outlook with a steady range in price targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $215 | $190 | $202.5 | $201.6 |
Analyst Sentiment
The current analyst sentiment reflects a conservative approach, with a majority expecting the stock to Hold.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 12 | |
| Hold | 19 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Quest Diagnostics presents a steady and reliable investment opportunity within the healthcare sector. Despite moderate financial ratios, the company's consistent performance and broad market reach underpin its potential. The stock aligns with a hold strategy as per current analyst sentiment, suitable for conservative portfolios. The risks of debt and the market volatility could influence the long-term growth prospects. Investors should weigh these factors against their portfolio objectives and risk tolerance.